GNRH1 and primary ovarian failure: Gonadotropin-releasing hormone (GnRH) analogs, by creation of an artificial prepubertal hypogonadotropic milieu and reduced utero-ovarian perfusion, may have a role in the prevention of chemotherapy-induced premature ovarian failure in an oncological setting [28].